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Abstract 
Blood culture is often used in definitive diagnosis of typhoid fever while, bone marrow culture has a greater sensitivity 
and considered reference standard. The sensitivity of blood culture measured against bone marrow culture results in 
measurement bias because both tests are not fully sensitive. Here we propose a combination of the two cultures as a 
reference to define true positive S. Typhi cases. Based on a systematic literature review, we identified ten papers that 
had performed blood and bone marrow culture for S. Typhi in same subjects. We estimated the weighted mean of 
proportion of cases detected by culture measured against true S. Typhi positive cases using a random effects model. 
Of 529 true positive S. Typhi cases, 61 % (95 % CI 52–70 %) and 96 % (95 % CI 93–99 %) were detected by blood 
and bone marrow cultures respectively. Blood culture sensitivity was 66 % (95 % CI 56–75 %) when compared with 
bone marrow culture results. The use of blood culture sensitivity as a proxy measure to estimate the proportion of 
typhoid fever cases detected by blood culture is likely to be an underestimate. As blood culture sensitivity is used as 
a correction factor in estimating typhoid disease burden, epidemiologists and policy makers should account for the 
underestimation.
© 2016 The Author(s) This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Typhoid fever is a fecal oral transmitted systemic disease 
caused by the Salmonella enterica serovar Typhi. Cul-
turing the bacteria from body fluids is the definitive test 
for the diagnosis of typhoid fever although inconclusive 
serological methods such as Widal test are commonly 
employed in many health care settings [1, 2]. The culture 
of S. Typhi can be done from many body fluids such as 
blood, bone marrow, urine, rose spot extracts, duodenal 
aspirates and stool, while the blood culture remains the 
mainstay of definitive diagnosis [1, 3]. However, blood 
culture sometimes does not identify the bacteria even 
if it exists in the blood because of many procedural and 
technical issues. It is known that the maximum blood 
culture yield will be achieved when bacteremia is at peak 
such as in the first to third week from the onset of the ill-
ness [1] The quantity of blood sample collected may play 
a role, with a higher quantity more likely to give bacterial 
growth. Specimen collection, storage and transportation 
condition is likely to affect blood culture yield besides the 
culture media used [1, 4, 5]. Furthermore, febrile patients 
often take antibiotics; self-administered, prescribed or 
un-prescribed, likely to reduce the possibility of bacterial 
growth because antibiotics may inhibit the growth of S. 
Typhi. Considering the sub-optimal diagnostic yield of 
blood culture, studies that estimate typhoid fever disease 
burden tend to apply “a blood culture sensitivity correc-
tion factor” to account for missed cases [6, 7].
The sensitivity of a test is defined as the probability that 
the test correctly classifies people with disease as posi-
tive [8]. In patients with typhoid fever, the blood culture 
sensitivity measures the proportion of the S. Typhi cases 
detected by blood culture compared to an independent 
test, commonly bone marrow culture. A previous litera-
ture review on the sensitivity of blood culture suggested 
40 to 60 % [9] acknowledging the widely accepted sensi-
tivity rate of 50 % [1] which is often used as a correction 
factor in many disease burden studies [6, 7, 10, 11]. The 
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blood culture sensitivity is measured against bone mar-
row culture which is often considered superior because it 
can yield bacteria among those who took antibiotics and 
even after the bacteremia subsides in the blood [1, 12]. 
Ironically, bone marrow culture is also subject to same 
methodological and technical limitations as blood cul-
ture and misses some typhoid fever cases besides posing 
clinical difficulties as an invasive procedure. There are a 
few studies that document typhoid fever cases that are 
bone marrow negative and blood culture positive [13–
15]. One of the clinical reviews has suggested a sensitivity 
of 40–80 % for blood culture and 55–67 % for bone mar-
row culture [3]. This indicates that the current practice 
of using blood culture sensitivity as a proxy to represent 
proportion of cases detected in disease burden studies 
has intrinsic bias of using a sub-optimal reference test 
against which it is measured.
Besides being used as a correction factor in the meas-
urement of disease burden estimates which play crucial 
role in policy making, the proportion of typhoid fever 
cases detected is important for clinicians. Even if the 
blood culture is negative for typhoid fever, the person 
still may be suffering from the disease and need treat-
ment. Thus understanding how many typhoid fever 
cases are actually detected by blood culture has critical 
importance for clinicians who would treat the patients, 
epidemiologists who estimate the disease incidence and 
policy makers who would use the data for decisions on 
control measures. As we argued that the blood culture 
sensitivity measured against bone marrow culture is 
not the true measure of the proportion of typhoid fever 
cases detected, here we present a new method. This 
method will be helpful in measuring the precise propor-
tion of typhoid fever cases detected when blood culture is 
deployed as a diagnostic test.
Methods
First, we chose two tests, blood culture and bone marrow 
culture to define an algorithm to estimate the propor-
tion of bacteremic typhoid fever cases identified by blood 
culture. As noted before, both tests do not identify all 
typhoid fever cases [3] and hence choosing one of them 
as a reference standard to compare against the other 
would be an imperfect estimation of the proportion of 
cases detected. Therefore, we considered a composite ref-
erence standard of two tests to define true positive cases 
based on epidemiological principles [16, 17] as described 
below.
Anybody who tested positive for typhoid fever either 
in blood or bone marrow culture was considered a true 
positive and the proportion of cases identified by each 
test was measured against true positive cases (Eq.  1). 
That means we could use only those subjects in whom 
both blood culture and bone marrow cultures were per-
formed. This method allows the measurement of the pro-
portion of cases detected by each test in comparison to 
true positive (Eqs. 2, 3). We compared our results to the 
sensitivity of blood culture compared against bone mar-
row culture results (Eq. 4). The decision matrix is shown 
in Table 1. The calculation can be represented as below.
where,
ProCasei = Proportion of typhoid fever cases detected 
by culture technique i in comparison to true positive 
cases detected based on both tests i and j.
ProCaseBC vs BMC = Proportion of typhoid fever cases 
detected by blood culture in comparison to typhoid fever 
cases detected by bone marrow culture.
TPi = True positive cases by culture technique i (cul-
ture test shows bacterial growth by culture technique i 
when the bacteria is present in the sample based on cul-
ture technique j).
FPi = False positive cases by culture technique i (cul-
ture test shows bacterial growth by culture technique i 
when no bacteria was detected in the sample by culture 
technique j).
FNi = False negative cases by culture technique i (cul-
ture test shows no bacteria growth in the sample by cul-
ture technique i when bacteria is present in the sample 
based on culture technique j).
TPj&i = True positive test for both culture techniques j 
and i (culture test shows bacterial growth in culture tech-
nique j when the bacteria is present in the sample based 
on culture technique i).
(1)ProCasei =
TPi + FPi
FNi + TPj&i + FNj
(2)ProCaseBC =
TPBC + FPBC
FNBC + TPBMC&BC + FNBMC
(3)ProCaseBMC =
TPBMC + FPBMC




Table 1 General decision matrix for  blood and  bone mar-
row diagnostic test
BC blood culture, BMC bone marrow culture, TP true positive, FP false positive, 
FN false negative, TN true negative
a Biological materials withdrawn from same patient
BMCa
+ve −ve
BCa +ve TPBC, BMC FPBC OR FNBMC
−ve FNBC OR FPBMC TNBC, BMC
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FNj = False negative cases by culture technique j (cul-
ture test shows no bacteria growth in the sample by cul-
ture technique j when bacteria is present in the sample 
based on culture technique i).
BC = Blood culture test.
BMC = Bone marrow culture test.
A systematic review of literature was conducted to 
assess the proportion of typhoid fever cases identified 
by blood culture. The search involved three databases; 
Medline as a primary electronic database, followed by 
Embase, WHO and Pan American Health Organisation 
(PAHO) websites to identify additional publications. 
The search was limited to studies published in English 
language, published before December 31, 2013 among 
human subjects. The key words used were (“typhoid” OR 
“typhoid fever” OR “Salmonella Typhi” OR “S. Typhi” OR 
“Salmonella infection” OR “enteric fever”) AND (“blood” 
OR “blood culture” OR “culture of blood” OR “diagnos-
tics” OR “sensitivity” OR “positivity”). The inclusion and 
exclusion criteria are given in Table  2. The search was 
conducted by an independent researcher; the results 
were verified by a second researcher for inclusion and 
exclusion criteria matching. Any differences between two 
researchers were resolved based on discussion and agree-
ment, if unresolved, third independent researcher made 
the final decision. All selected papers were reviewed 
by a third researcher before data extraction to confirm 
its adherence to inclusion criteria. In the final list, we 
included papers that conducted both blood and bone 
marrow culture in same set of patients.
Last, the selected publications were reviewed to cal-
culate true positive, false positive, true negative and 
false negative cases from blood and bone marrow cul-
ture results in the same patients. We estimated the case 
weighted mean proportion of S. Typhi detected from 
selected studies using random effects model. The observa-
tions on culture media, volume of blood sample collected 
and duration of illness were presented descriptively.
Results
The systematic literature search in PubMed and Embase 
as well as WHO and PAHO websites produced 5922 
papers. A total 5831 studies were excluded because of 
duplication and not fitting with inclusion criteria on 
review of the title and abstract (Fig.  1). Of the remain-
ing 91 papers, six full-text articles were inaccessible, 64 
papers used a single diagnostic test (either blood or bone 
marrow), seven were review papers, one used animal 
samples for investigating the impact of S. Typhimurium 
on humans, and three papers did not differentiate results 
for S. Typhi and S. Paratyphi A. Finally, 10 papers were 
selected including one from Western Africa [13], one 
from South Africa [18], one from South Asia [19], four 
from South-East Asia [14, 20–22] and three from Latin 
America [15, 23, 24] (Table 3).
The ten studies tested 635 people for S. Typhi using 
both blood and bone marrow cultures. Of 529 true S. 
Typhi positive cases the proportion of S. Typhi detection 
was 61 % (95 % CI 52–70 %) and 96 % (95 % CI 93–99 %) 
for blood and bone marrow culture respectively (Fig. 2). 
The sensitivity of blood culture was found to be 66  % 
(95  % CI 56–75  %) when bone marrow culture results 
were used as the reference standard comparator.
The recovery of S. Typhi varied depending upon the 
bacteriological culture media used [21, 22], the volume of 
blood samples collected [22] and duration of the disease 
[15, 24]. The Luria-Betani (LB) broth media resulted in 
better recovery compared to Difco Oxgal with Selenite F 
broth media (44/54 vs. 19/43 respectively) [15, 20]. Nev-
ertheless the lower yield from Difco Oxgal broth could 
be because many studies used blood volumes of less 
than 3 ml and the same media showed improved recov-
ery where ≥5 ml blood was used [14, 22]. Some studies 
showed that the collection of a 15  ml of blood sample 
increased the sensitivity of blood culture comparable 
to that of the bone marrow culture [9, 22]. The earlier a 
patient reports to a health facility, the better the recovery 
of S. Typhi organism in blood cultures and bone marrow 
cultures [14, 20, 22].
Discussion
This review presents a summary of the proportion of S. 
Typhi cases detected by blood culture based on the com-
bined results of blood and bone marrow culture in the 
same individuals. The results indicate that 2 out of 5 peo-
ple infected with S. Typhi would remain undiagnosed if 
blood culture were deployed as the diagnostic test. The 
results also imply that even if bone marrow culture were 
used, 1 in 25 people infected with S. Typhi would remain 
undiagnosed. Clinicians should be aware and remember 
these missed diagnoses in case management. It is likely 
that even the combination of blood culture and bone 
Table 2 Inclusion and exclusion criteria
Inclusion criteria
 Listed in PubMed, Embase database, WHO or PAHO databases
 Published before 31st December 2013
 Conducted in human subjects
 Published in English language
 Collected blood and bone marrow samples from same patients for S. 
Typhi detection
 Identified by search terms defined in the text
 Study design: Laboratory surveillance
Exclusion criteria
 Papers that do not distinguish S. Typhi from S. Paratyphi in blood culture 
results
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marrow will not diagnose all patients with typhoid fever 
but in the absence of a perfect reference standard test 
this is difficult to confirm. Most importantly, the find-
ings indicate that the proportion of typhoid fever cases 
detected by blood culture is lower than the blood cul-
ture sensitivity measured against bone marrow culture. 
This has important public health ramifications in typhoid 
fever control because blood culture sensitivity is often 
used as s a proxy for the proportion of S. Typhi detected 
in correcting disease burden estimates.
Previous global disease burden estimates [10, 11] and 
incidence studies [6, 7] have used 50 % blood culture sen-
sitivity as a proxy measure for the proportion of cases 
detected by blood culture while this review suggests 
a higher value of 61  %. If this higher proportion were 
used as a correction factor in estimating the incidence, 
the disease burden decreases. In recent typhoid disease 
burden estimations in low and middle income countries, 
the authors have clearly demonstrated these differences 
through a sensitivity analysis. The study estimated 25.3 
million cases when 50 % blood culture sensitivity correc-
tion was used which declined to 20.6 million cases when 
61  % blood culture correction was deployed [25]. Such 
variation in the disease burden estimation may influence 
global policy and financing decisions, hence careful con-
siderations in using these results are necessary. Notably 
we argue that the blood culture sensitivity should not 
be used as a proxy for the proportion of S. Typhi cases 
detected because it undermines the disease burden esti-
mates. In this review we found blood culture sensitivity 
was 66  % using bone marrow culture as the reference 
standard. If we use this sensitivity in previous disease 
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Fig. 1 PRISMA diagram for systematic literature review. Asterisk No conformity to inclusion criteria because 35 papers used single diagnostic test, 
either blood or bone marrow; 7 were review papers, 1 used animal sample for investigating the impact of S. Typhimurium on human and 6 papers 
were inaccessible. Double Asterisk 29 had used only blood culture for typhoid fever confirmation; three papers did not differentiate results for S. 
Typhi and S. Paratyphi A
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Fig. 2 Forest plot for the proportion of S. Typhi detected and for blood culture sensitivity based on ten studies identified in the systematic literature 
review. ProcaseBC Proportion of S. Typhi positive blood cultures among true positive S. Typhi positive cases (either blood or bone marrow cultures 
positive for S. Typhi when specimens were collected from same patients), ProCaseBMC Proportion of S. Typhi positive bone marrow cultures among 
true positive S. Typhi positive cases (either blood or bone marrow cultures positive for S. Typhi when specimens were collected from same patients; 
ProCaseBC vs. BMC Sensitivity of blood culture measured against bone marrow culture positive cases as reference standard
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burden estimates [25], the typhoid fever burden in low 
and middle income countries decreases by 1.5 million; 
from estimated 20.6 million to 19.1 million.
Our study has several limitations which should be con-
sidered carefully before applying the summary informa-
tion to clinical, epidemiological and policy decisions. 
First, it is well known that the bacterial growth in cul-
ture is dependent on the time from the onset of illness 
and sample collection; greater recovery was observed in 
early bacteremic phase. We could not account for time 
factor in our analysis as such detailed information was 
unavailable in the papers identified. It is possible that 
some studies could have collected samples early after 
the disease onset and others in a later stage resulting 
in inter observational biases. Had we known the time 
of sample collection for all studies, we could have pre-
sented sensitivity as a factor of time. Second, sampling 
the same febrile case in our analysis may not mean that 
blood and bone marrow samples were collected simulta-
neously. We only know that same person had provided 
both blood and bone marrow culture samples. As com-
monly practiced, bone marrow sample might have been 
collected in a later stage of the disease management or 
after antibiotic prescription. In this case, it could be pos-
sible that those who were tested negative for blood cul-
ture might have been sampled for bone marrow which 
would create a blood culture sensitivity underestimation 
bias. Third, the volume of specimen collected will have 
differed between blood and bone marrow and between 
different studies which might have introduced the bias 
in bacterial isolation as larger the volume of the sam-
ple, higher the yield would be. Studies of the quantita-
tive bacteriology of the blood and bone marrow suggest 
that the bacterial counts in bone marrow may be 10-fold 
higher than blood so larger volumes of blood maybe 
comparable with smaller volumes of bone marrow aspi-
rate [26]. Many studies identified in this review were 
conducted several decades ago and had collected smaller 
volume of blood as per the prevalent practices at that 
time. Similarly, different culture media were employed in 
different studies which may have influenced the results 
as the potential for bacterial growth may differ between 
the culture media. None of the studies identified by this 
review used the commercial media that are now com-
monly used for culture [27]. Also, as these studies were 
conducted in different time periods (1955–2001), in 
different geographical regions, in different endemic-
ity locations, and in different clinical and laboratory 
settings; inter study variation may have influenced the 
results. Forth, three papers did not separate reports 
for S. Typhi and S. Paratyphi A cases, which led to the 
exclusion of those papers from the analysis. We can-
not predict if the inclusion of such studies would have 
altered the results. Fifth, as both blood and bone mar-
row cultures are partially sensitive, the composite refer-
ence standard may have still missed some typhoid fever 
cases. In that situation, the proportion or the S. Typhi 
detected could be an overestimation. The true propor-
tion of cases detected and true sensitivity of culture can 
only be measured against a perfect test that is fully sen-
sitive and specific. Molecular diagnostic tests may hold 
the promise for future to provide better composite ref-
erence standard, if not perfect [3]. Sixth, as bone mar-
row culture is an invasive procedure, there is an intrinsic 
procedural difficulty that may have discouraged the cli-
nicians from performing the procedure; or may have 
restrained patients or guardians from giving procedural 
consent. This may have introduced differential sample 
collection bias between blood and bone marrow culture. 
We could not measure this bias in our study because 
information on failed procedures or people did not con-
sent for procedure was not presented in the papers. Sev-
enth, the blood and bone marrow cultures could only be 
performed in health facilities sufficiently equipped for 
the complexity of both procedures and with accessible 
skilled personnel. This means the selected papers could 
represent the proportion of cases detected and the sen-
sitivity at higher quality health facilities which need not 
be the same as the health facilities where only blood cul-
ture is performed. Thus the true blood culture sensitiv-
ity or proportion of cases identified at a primary health 
facility or a remote health facility or a community based 
health facility where typhoid fever surveillance is con-
ducted may differ. Eight, most studies had small sample 
size; largest being 103, resulted in wide confidence inter-
vals. Studies with larger sample size in future will help 
in reducing the uncertainty. Finally, the literature search 
only included studies published in English which may 
have resulted in missing some papers published in other 
languages.
Conclusion
The proportion of S. Typhi detected by blood culture 
estimated from this systematic literature review provides 
a point estimate and range for correcting missed typhoid 
fever cases in disease burden studies based on a scientific 
rationale. The estimated blood culture sensitivity in this 
review is higher than the commonly reported value. We 
question the use of blood culture sensitivity as a proxy 
for the proportion of S. Typhi cases detected in disease 
burden measures as it underestimates the real problem. 
This information should be used by clinicians, epidemi-
ologists and decision makers in making rational and logi-
cal decisions. Future research should focus on measuring 
proportion of typhoid fever cases detected by blood cul-
ture based on standardized concurrent blood and bone 
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marrow culture or other reasonable reference standard 
in the field settings which will help in understanding 
the true proportion of S. Typhi cases identified by blood 
culture.
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